×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Percutaneous Coronary Intervention Market Size

ID: MRFR/MED/2288-CR
157 Pages
Rahul Gotadki
January 2024

Percutaneous Coronary Intervention Market Research Report Information by Product Type (Coronary Stents, Balloon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostics Catheters, Crossing Catheters, Inflation Devices, Guidance Systems, Peripheral Thrombectomy System, Embolic Protection System, And Accessories), by Vascular Access (Radial and Femoral), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Percutaneous Coronary Intervention Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Percutaneous Coronary Intervention Size

Percutaneous Coronary Intervention Market Growth Projections and Opportunities

Percutaneous Coronary Intervention (PCI), a minimally invasive method for unblocking coronary arteries, is witnessing increased adoption driven by the growing incidence of heart diseases and a preference for less invasive procedures. Despite these positive trends, the market faces challenges due to infection risks. However, ongoing technological advancements present opportunities for global market leaders to further enhance PCI procedures, making them safer and more effective. The escalating prevalence of heart diseases worldwide has fueled the demand for PCI as an effective and less invasive treatment option. Patients and healthcare professionals alike are increasingly favoring minimally invasive procedures due to their associated benefits, including reduced recovery time and lower risk of complications.

While the market for PCI is on the rise, the potential threat of infections poses a challenge to its sustained growth. Infection risks associated with medical procedures are a concern that needs to be addressed to ensure the continued acceptance of PCI. Medical professionals and researchers are actively exploring ways to mitigate these risks and enhance the safety profile of PCI.

Despite the challenges, the PCI market holds promise, driven by continuous technological advancements. Innovations in medical technology are paving the way for enhanced PCI procedures, making them more precise, efficient, and safer for patients. The integration of cutting-edge technologies into PCI, such as improved imaging techniques and advanced catheter technologies, is expected to elevate the overall success and safety of these procedures.

Global market leaders in the medical field are well-positioned to capitalize on the opportunities presented by technological advancements in PCI. Collaborations, research initiatives, and investments in innovative solutions can contribute to the development of next-generation PCI procedures. This not only addresses existing challenges but also establishes a pathway for sustained market growth.

Collaborative efforts among healthcare professionals, researchers, and industry leaders play a crucial role in navigating the evolving landscape of PCI. By fostering partnerships and investing in research and development, the global medical community can address existing challenges, enhance patient safety, and drive continuous innovation in the field. This collaborative approach not only ensures the sustainability of the PCI market but also reinforces its position as a transformative solution in the realm of cardiac interventions.

Percutaneous Coronary Intervention Market Size Graph
Author
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Percutaneous Coronary Intervention Market by 2035?

<p>The projected market valuation for the Percutaneous Coronary Intervention Market is expected to reach 33.48 USD Billion by 2035.</p>

What was the market valuation of the Percutaneous Coronary Intervention Market in 2024?

<p>The overall market valuation was 11.7 USD Billion in 2024.</p>

What is the expected CAGR for the Percutaneous Coronary Intervention Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Percutaneous Coronary Intervention Market during the forecast period 2025 - 2035 is 10.03%.</p>

Which application segment is projected to have the highest valuation by 2035?

<p>The Coronary Artery Disease application segment is projected to reach 13.25 USD Billion by 2035.</p>

What are the key players in the Percutaneous Coronary Intervention Market?

<p>Key players in the market include Abbott, Boston Scientific, Medtronic, Johnson & Johnson, B. Braun, Terumo, Cardinal Health, Siemens Healthineers, and Philips.</p>

Which device type is expected to dominate the market by 2035?

<p>Stents are expected to dominate the market, projected to reach 16.73 USD Billion by 2035.</p>

What is the projected valuation for the Emergency Procedures segment by 2035?

The Emergency Procedures segment is projected to reach 10.05 USD Billion by 2035.

How does the market for Drug-Eluting Stents compare to Bare-Metal Stents by 2035?

By 2035, the market for Drug-Eluting Stents is projected to reach 17.5 USD Billion, significantly higher than the 10.0 USD Billion for Bare-Metal Stents.

What is the expected growth trend for Cardiac Catheterization Labs as an end user by 2035?

Cardiac Catheterization Labs are expected to grow, reaching a valuation of 10.05 USD Billion by 2035.

What is the projected market size for Ambulatory Surgical Centers by 2035?

The projected market size for Ambulatory Surgical Centers is expected to reach 10.05 USD Billion by 2035.

Market Summary

As per MRFR analysis, the Percutaneous Coronary Intervention Market Size was estimated at 11.7 USD Billion in 2024. The Percutaneous Coronary Intervention industry is projected to grow from 12.87 USD Billion in 2025 to 33.48 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 10.03% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Percutaneous Coronary Intervention Market is poised for substantial growth driven by technological advancements and increasing disease prevalence.

  • North America remains the largest market for percutaneous coronary interventions, reflecting a robust healthcare infrastructure.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and increasing patient populations.
  • Coronary artery disease continues to dominate the market, while acute coronary syndrome is recognized as the fastest-growing segment.
  • Technological advancements and regulatory support are key drivers propelling market growth, alongside the rising prevalence of cardiovascular diseases.

Market Size & Forecast

2024 Market Size 11.7 (USD Billion)
2035 Market Size 33.48 (USD Billion)
CAGR (2025 - 2035) 10.03%
Largest Regional Market Share in 2024 North America

Major Players

Abbott (US), Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), B. Braun (DE), Terumo (JP), Cardinal Health (US), Siemens Healthineers (DE), Philips (NL)

Market Trends

The Percutaneous Coronary Intervention Market is currently experiencing notable transformations driven by advancements in technology and increasing demand for minimally invasive procedures. As healthcare providers seek to enhance patient outcomes, innovations in catheter design, imaging techniques, and stent technology are becoming more prevalent. These developments not only improve procedural efficiency but also reduce recovery times, thereby appealing to both patients and healthcare professionals. Furthermore, the growing prevalence of cardiovascular diseases is prompting a shift towards proactive management strategies, which may further bolster the market's expansion. In addition to technological advancements, the Percutaneous Coronary Intervention Market is influenced by evolving regulatory frameworks and reimbursement policies. As governments and health organizations strive to improve access to care, there appears to be a concerted effort to streamline approval processes for new devices and procedures. This regulatory support could facilitate the introduction of innovative solutions, ultimately enhancing the quality of care provided to patients. Overall, the market seems poised for growth, driven by a combination of technological progress and supportive policy environments.

Technological Advancements

The ongoing evolution of technology in the Percutaneous Coronary Intervention Market is reshaping treatment methodologies. Innovations in catheter designs, imaging modalities, and stent materials are enhancing procedural outcomes and patient safety. These advancements are likely to lead to more effective interventions and improved recovery experiences.

Regulatory Support

The regulatory landscape surrounding the Percutaneous Coronary Intervention Market is evolving, with authorities increasingly focused on expediting the approval of new devices and techniques. This regulatory support may facilitate the introduction of cutting-edge solutions, thereby enhancing patient access to advanced care.

Rising Cardiovascular Disease Prevalence

The increasing incidence of cardiovascular diseases is driving demand within the Percutaneous Coronary Intervention Market. As healthcare systems prioritize early intervention and management strategies, the market is expected to expand, reflecting a growing emphasis on proactive healthcare solutions.

Percutaneous Coronary Intervention Market Market Drivers

Market Growth Projections

The Global Percutaneous Coronary Intervention Market Industry is on a trajectory of substantial growth, with projections indicating a market size of 11.7 USD Billion in 2024 and an anticipated increase to 33.5 USD Billion by 2035. This growth reflects a compound annual growth rate of 10.03% from 2025 to 2035, driven by factors such as rising cardiovascular disease prevalence, technological advancements, and increased healthcare expenditure. These projections highlight the dynamic nature of the PCI market and its critical role in addressing global cardiovascular health challenges.

Growing Geriatric Population

The demographic shift towards an aging population is a crucial factor propelling the Global Percutaneous Coronary Intervention Market Industry. As individuals age, the risk of developing cardiovascular diseases escalates, necessitating more frequent interventions. By 2030, it is anticipated that the number of people aged 60 and older will surpass 1.4 billion globally, creating a substantial demand for PCI procedures. This demographic trend underscores the need for healthcare systems to adapt and expand their cardiovascular care capabilities, thereby driving market growth in the coming years.

Increased Healthcare Expenditure

Rising healthcare expenditure across various regions is a significant driver of the Global Percutaneous Coronary Intervention Market Industry. Governments and private sectors are investing more in healthcare infrastructure, particularly in cardiovascular care. This trend is evident in many countries where healthcare budgets are being allocated to advanced medical technologies and procedures. As a result, the market is poised for growth, with a projected compound annual growth rate of 10.03% from 2025 to 2035, reflecting the increasing prioritization of cardiovascular health in national health agendas.

Enhanced Awareness and Screening Programs

The growing awareness of cardiovascular health and the implementation of screening programs are pivotal in shaping the Global Percutaneous Coronary Intervention Market Industry. Public health initiatives aimed at educating populations about heart disease risk factors have led to earlier detection and treatment of cardiovascular conditions. This proactive approach not only improves patient outcomes but also drives demand for PCI procedures. As awareness continues to rise, the market is likely to experience sustained growth, further emphasizing the importance of preventive care in cardiovascular health.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases globally serves as a primary driver for the Global Percutaneous Coronary Intervention Market Industry. With an estimated 17.9 million deaths attributed to cardiovascular conditions each year, the demand for effective treatment options is surging. Percutaneous coronary interventions, which include angioplasty and stenting, are becoming essential in managing these diseases. As healthcare systems adapt to this growing burden, the market is projected to reach 11.7 USD Billion in 2024, reflecting the urgent need for innovative solutions in cardiovascular care.

Technological Advancements in PCI Procedures

Technological innovations in percutaneous coronary interventions are significantly influencing the Global Percutaneous Coronary Intervention Market Industry. Advancements such as drug-eluting stents, bioresorbable stents, and improved imaging techniques enhance procedural outcomes and patient safety. These innovations not only improve the efficacy of interventions but also reduce recovery times, leading to increased patient throughput in healthcare facilities. As a result, the market is expected to expand, with projections indicating a growth to 33.5 USD Billion by 2035, driven by the continuous evolution of PCI technologies.

Market Segment Insights

By Application: Coronary Artery Disease (Largest) vs. Acute Coronary Syndrome (Fastest-Growing)

In the Percutaneous Coronary Intervention (PCI) market, the application of treatments for Coronary Artery Disease (CAD) holds the largest market share. CAD has become more prevalent due to factors such as aging populations and lifestyles that increase cardiovascular risk. This segment accounts for a significant portion of PCI procedures, highlighting its critical role in cardiac health management. Meanwhile, Acute Coronary Syndrome (ACS) is witnessing rapid growth, driven by increasing awareness of heart disease and advancements in PCI technologies. As urgency in treating ACS rises, so does the application of PCI techniques tailored to this condition.

Coronary Artery Disease (Dominant) vs. Acute Coronary Syndrome (Emerging)

Coronary Artery Disease (CAD) remains the dominant application in the PCI market, largely due to its widespread occurrence among patients with historical risk factors. This segment encompasses various interventions targeted at improving coronary blood flow and alleviating symptoms of cardiovascular distress. Conversely, Acute Coronary Syndrome (ACS) is emerging as a fast-growing area owing to heightened incidences and a shift towards more immediate treatment protocols. As healthcare providers focus on quick response and intervention for ACS cases. The market demonstrates a shift towards innovative techniques and technologies that enhance outcomes for patients experiencing acute cardiac events.

By Device Type: Stents (Largest) vs. Balloon Catheters (Fastest-Growing)

In the Percutaneous Coronary Intervention Market, the segment of device types is characterized by distinct shares among balloon catheters, stents, guidewires, and sheaths. Stents hold the largest market share owing to their critical role in maintaining arterial patency and preventing restenosis. Balloon catheters have also carved a significant niche; however, their market presence is bolstered by innovative designs that enhance treatment outcomes, attracting a growing segment of healthcare practitioners. The growth trends within this segment reveal a notable surge in the adoption of balloon catheters, which are emerging as the fastest-growing devices due to advances in technology and increased preference for minimally invasive procedures. The prevalence of cardiovascular diseases drives demand for effective intervention devices, with healthcare providers increasingly opting for devices that offer greater efficacy and patient safety, fueling the expansive growth of the percutaneous coronary intervention market.

Stents (Dominant) vs. Guidewires (Emerging)

Stents dominate the Percutaneous Coronary Intervention Market by providing exceptional support in preventing artery blockage, becoming a cornerstone in atherosclerosis treatment. Their biocompatible materials and drug-eluting technologies contribute to their widespread use. As they evolve, stents are witnessing enhancements such as bioresorbable options, which are anticipated to further strengthen their position. On the other hand, guidewires are classified as an emerging segment, playing a crucial role in facilitating the placement of other devices within coronary arteries. Their advancements focus on high flexibility and torque response, which allow for intricate navigations within vascular systems. The growing emphasis on complex interventions signals potential growth for guidewires, as they are essential for the successful execution of various coronary procedures.

By End User: Hospitals (Largest) vs. Cardiac Catheterization Labs (Fastest-Growing)

In the Percutaneous Coronary Intervention Market, hospitals hold the largest share of the end-user segment, given their comprehensive facilities and skilled personnel. They cater to a broad patient demographic, from elective procedures to emergency interventions, thus solidifying their market dominance. Cardiac catheterization labs follow, reflecting a significant portion of the market share. These specialized centers play an important role by providing targeted services, which appeals to a niche patient base seeking dedicated cardiac care, greatly influencing overall market dynamics. Growth trends are indicating a gradual shift toward cardiac catheterization labs as they offer enhanced efficiency and faster patient recovery times. This segment is expected to see rapid advancements driven by technological innovations, improving procedural outcomes. Simultaneously, hospitals continue to adapt by integrating more sophisticated equipment, which helps to attract a high volume of cardiac patients. Together, these trends reflect evolving patient care preferences and advancements in procedural technologies within the market.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals are the dominant end-user in the Percutaneous Coronary Intervention Market, characterized by their extensive resources, including advanced diagnostic and interventional technologies, along with a comprehensive team of specialists. The integration of surgical and critical care facilities within hospitals ensures a holistic approach to patient management, catering to diverse cardiac conditions. In contrast, ambulatory surgical centers are emerging as a significant player in the market due to their cost-effectiveness and ability to perform procedures with reduced hospital admissions. These centers provide a more convenient option for patients due to shorter wait times and typically faster recovery periods. As healthcare continues to shift toward outpatient services, ambulatory surgical centers are expected to gain traction, offering competitive services alongside hospitals.

By Procedure Type: Elective Procedures (Largest) vs. Emergency Procedures (Fastest-Growing)

In the Percutaneous Coronary Intervention Market, the distribution of procedure types reveals that elective procedures dominate the landscape, comprising a significant majority of the market share. These procedures are often planned in advance, allowing for effective resource allocation and patient management, thus overshadowing the other categories. Meanwhile, emergency procedures have gained notable traction, particularly in light of rising cardiovascular diseases, pushing them into a rapidly growing segment driven by urgent healthcare needs.

Elective Procedures (Dominant) vs. Emergency Procedures (Emerging)

Elective procedures are characterized by their planned nature, often allowing patients to choose their timing and setting, which helps maintain a steady workflow in healthcare facilities. In contrast, emergency procedures cater to acute cardiac events that require immediate intervention, thereby marking their emergence in the market. The growing prevalence of coronary diseases and the need for timely interventions are driving factors behind the increasing adoption of emergency procedures. Both segments play critical roles in the overall structure; however, elective procedures continue to maintain a robust foothold due to established protocols and patient preferences.

By Technology: Drug-Eluting Stents (Largest) vs. Bioabsorbable Stents (Fastest-Growing)

<p>In the Percutaneous Coronary Intervention Market, Drug-Eluting Stents (DES) hold the largest share, gaining prominence due to their ability to prevent restenosis and improve patient outcomes. Following DES, Bare-Metal Stents (BMS) continue to be a reliable choice due to their availability and lower cost, while Bioabsorbable Stents are emerging, capturing interest for their innovative design aimed at promoting natural vessel healing. Together, these segments contribute to a dynamic landscape within the market.</p>

<p>Technology: Drug-Eluting Stents (Dominant) vs. Bioabsorbable Stents (Emerging)</p>

<p>Drug-Eluting Stents are at the forefront of the Percutaneous Coronary Intervention Market, favored for their drug-release mechanism that reduces the incidence of restenosis effectively, thus providing longer-term solutions for patients. On the other hand, Bioabsorbable Stents represent an innovative trend aimed at addressing limitations associated with traditional stents, such as maintaining optimal vessel function post-procedure. As these stents dissolve over time, they engage the body’s healing processes more naturally. While currently considered an emerging technology, their potential for faster adoption is fueled by advancements in materials science and increasing focus on personalized medicine.</p>

Get more detailed insights about Percutaneous Coronary Intervention Market Research Report — Global Forecast till 2035

Regional Insights

North America : Market Leader in Innovation

North America is poised to maintain its leadership in the Percutaneous Coronary Intervention (PCI) market, holding a significant market share of 6.0 in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong emphasis on research and development. Regulatory support from agencies like the FDA further catalyzes innovation, ensuring rapid adoption of new technologies and procedures. The competitive landscape in North America is robust, featuring key players such as Abbott, Boston Scientific, and Medtronic. These companies are at the forefront of technological advancements, offering a range of innovative PCI devices. The U.S. remains the largest market, supported by high healthcare expenditure and a growing aging population. This dynamic environment fosters continuous improvement and expansion in PCI offerings, solidifying North America's position as a global leader.

Europe : Emerging Market with Growth Potential

Europe's PCI market is characterized by a market size of 3.5, reflecting a growing demand for minimally invasive cardiac procedures. The region benefits from a well-established healthcare system, increasing awareness of cardiovascular health, and supportive regulatory frameworks. Initiatives by the European Medicines Agency (EMA) promote innovation and ensure patient safety, driving market growth and adoption of advanced PCI technologies. Leading countries in Europe include Germany, France, and the UK, where major players like B. Braun and Siemens Healthineers are actively expanding their market presence. The competitive landscape is marked by collaborations and partnerships aimed at enhancing product offerings. As the region continues to invest in healthcare technology, the PCI market is expected to witness significant advancements, catering to the rising demand for effective cardiac interventions.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific region, with a market size of 1.8, is rapidly emerging as a significant player in the PCI market. Factors such as increasing urbanization, rising disposable incomes, and a growing prevalence of lifestyle-related diseases are driving demand for PCI procedures. Governments are also investing in healthcare infrastructure, which is expected to further boost market growth. Regulatory bodies are working to streamline approval processes for new devices, enhancing market accessibility. Countries like Japan, China, and India are leading the charge in this region, with key players such as Terumo and Cardinal Health expanding their operations. The competitive landscape is evolving, with local manufacturers entering the market, increasing competition. As healthcare systems improve and awareness of cardiovascular health rises, the Asia-Pacific region is set to experience substantial growth in PCI procedures and technologies.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa (MEA) region, with a market size of 0.4, presents untapped opportunities in the PCI market. The growth is driven by increasing healthcare investments, rising awareness of cardiovascular diseases, and a growing population. Governments are focusing on improving healthcare access and quality, which is expected to enhance the adoption of PCI procedures. Regulatory bodies are also working to establish frameworks that support the introduction of innovative medical technologies. Countries like South Africa and the UAE are leading the way in PCI adoption, with a growing number of healthcare facilities offering advanced cardiac care. The competitive landscape is gradually evolving, with both local and international players entering the market. As healthcare infrastructure improves and patient awareness increases, the MEA region is poised for significant growth in the PCI sector, attracting investments and innovations.

Key Players and Competitive Insights

The Percutaneous Coronary Intervention Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing prevalence of cardiovascular diseases, and a growing aging population. Major players such as Abbott (US), Boston Scientific (US), and Medtronic (US) are strategically positioned to leverage innovation and expand their market presence. Abbott (US) focuses on enhancing its product portfolio through continuous innovation, while Boston Scientific (US) emphasizes strategic partnerships to bolster its research and development capabilities. Medtronic (US) is actively pursuing mergers and acquisitions to enhance its technological capabilities and market reach, collectively shaping a competitive environment that is increasingly focused on advanced therapeutic solutions.Key business tactics within the market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and services, catering to varying patient needs and preferences, while also fostering innovation through competition.

In November Abbott (US) announced the launch of its latest drug-eluting stent, which incorporates advanced polymer technology aimed at improving patient outcomes. This strategic move is significant as it not only enhances Abbott's product offerings but also positions the company to capture a larger share of the market by addressing the growing demand for effective coronary interventions. The introduction of this innovative stent is expected to strengthen Abbott's competitive edge in a rapidly evolving market.

In October Boston Scientific (US) entered into a collaboration with a leading digital health company to integrate AI-driven analytics into its cardiac intervention devices. This partnership is pivotal as it reflects the increasing trend towards digitalization in healthcare, enabling Boston Scientific to offer enhanced patient monitoring and personalized treatment options. Such strategic alliances are likely to redefine the competitive landscape by fostering innovation and improving patient care.

In September Medtronic (US) completed the acquisition of a promising startup specializing in minimally invasive cardiac devices. This acquisition is indicative of Medtronic's commitment to expanding its technological capabilities and diversifying its product range. By integrating innovative solutions from the startup, Medtronic aims to enhance its competitive positioning and address the evolving needs of healthcare providers and patients alike.

As of December current competitive trends in the Percutaneous Coronary Intervention Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering collaboration that drives innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, innovative solutions, and reliable supply chains. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the market.

Key Companies in the Percutaneous Coronary Intervention Market include

Industry Developments

  • In January 2023, MicroPort Scientific Corporation (China) received marketing approval for “MicroPort Coronary Balloon Catheters” in Peru. By this product approval company expand its business in Peru and support.
  • In August 2022, Medtronic (Ireland) launched the Onyx Frontier drug-eluting stent (DES) System. The Onyx Frontier DES offers a unique delivery mechanism, built upon the acute performance and clinical data of the Resolute Onyx drug-eluting stent.
  • In March 2022, MicroPort Scientific Corporation (China) received marketing approval from approval from Japan Pharmaceuticals and Medical Devices Agency (PMDA) for its product “Hyperflex”. The company can market its products in Japan and boost the revenue growth.

Future Outlook

Percutaneous Coronary Intervention Market Future Outlook

The Percutaneous Coronary Intervention Market is projected to grow at a 10.03% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditure.

New opportunities lie in:

  • Development of advanced biodegradable stents for improved patient outcomes.
  • Integration of AI-driven analytics for personalized treatment plans.
  • Expansion of telehealth services for remote patient monitoring and follow-up.

By 2035, the market is expected to achieve substantial growth, reflecting enhanced treatment options and patient accessibility.

Market Segmentation

Percutaneous Coronary Intervention Market End User Outlook

  • Hospitals
  • Cardiac Catheterization Labs
  • Ambulatory Surgical Centers

Percutaneous Coronary Intervention Market Application Outlook

  • Coronary Artery Disease
  • Acute Coronary Syndrome
  • Stable Angina
  • Unstable Angina

Percutaneous Coronary Intervention Market Device Type Outlook

  • Balloon Catheters
  • Stents
  • Guidewires
  • Sheaths

Percutaneous Coronary Intervention Market Procedure Type Outlook

  • Elective Procedures
  • Emergency Procedures
  • Diagnostic Procedures

Report Scope

MARKET SIZE 2024 11.7(USD Billion)
MARKET SIZE 2025 12.87(USD Billion)
MARKET SIZE 2035 33.48(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 10.03% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Abbott (US), Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), B. Braun (DE), Terumo (JP), Cardinal Health (US), Siemens Healthineers (DE), Philips (NL)
Segments Covered Application, Device Type, End User, Procedure Type
Key Market Opportunities Integration of advanced imaging technologies enhances precision in the Percutaneous Coronary Intervention Market.
Key Market Dynamics Technological advancements and regulatory changes drive competitive dynamics in the Percutaneous Coronary Intervention Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Percutaneous Coronary Intervention Market by 2035?

<p>The projected market valuation for the Percutaneous Coronary Intervention Market is expected to reach 33.48 USD Billion by 2035.</p>

What was the market valuation of the Percutaneous Coronary Intervention Market in 2024?

<p>The overall market valuation was 11.7 USD Billion in 2024.</p>

What is the expected CAGR for the Percutaneous Coronary Intervention Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Percutaneous Coronary Intervention Market during the forecast period 2025 - 2035 is 10.03%.</p>

Which application segment is projected to have the highest valuation by 2035?

<p>The Coronary Artery Disease application segment is projected to reach 13.25 USD Billion by 2035.</p>

What are the key players in the Percutaneous Coronary Intervention Market?

<p>Key players in the market include Abbott, Boston Scientific, Medtronic, Johnson & Johnson, B. Braun, Terumo, Cardinal Health, Siemens Healthineers, and Philips.</p>

Which device type is expected to dominate the market by 2035?

<p>Stents are expected to dominate the market, projected to reach 16.73 USD Billion by 2035.</p>

What is the projected valuation for the Emergency Procedures segment by 2035?

The Emergency Procedures segment is projected to reach 10.05 USD Billion by 2035.

How does the market for Drug-Eluting Stents compare to Bare-Metal Stents by 2035?

By 2035, the market for Drug-Eluting Stents is projected to reach 17.5 USD Billion, significantly higher than the 10.0 USD Billion for Bare-Metal Stents.

What is the expected growth trend for Cardiac Catheterization Labs as an end user by 2035?

Cardiac Catheterization Labs are expected to grow, reaching a valuation of 10.05 USD Billion by 2035.

What is the projected market size for Ambulatory Surgical Centers by 2035?

The projected market size for Ambulatory Surgical Centers is expected to reach 10.05 USD Billion by 2035.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Application (USD Billion)
    2. | | 4.1.1 Coronary Artery Disease
    3. | | 4.1.2 Acute Coronary Syndrome
    4. | | 4.1.3 Stable Angina
    5. | | 4.1.4 Unstable Angina
    6. | 4.2 Healthcare, BY Device Type (USD Billion)
    7. | | 4.2.1 Balloon Catheters
    8. | | 4.2.2 Stents
    9. | | 4.2.3 Guidewires
    10. | | 4.2.4 Sheaths
    11. | 4.3 Healthcare, BY End User (USD Billion)
    12. | | 4.3.1 Hospitals
    13. | | 4.3.2 Cardiac Catheterization Labs
    14. | | 4.3.3 Ambulatory Surgical Centers
    15. | 4.4 Healthcare, BY Procedure Type (USD Billion)
    16. | | 4.4.1 Elective Procedures
    17. | | 4.4.2 Emergency Procedures
    18. | | 4.4.3 Diagnostic Procedures
    19. | 4.5 Healthcare, BY Technology (USD Billion)
    20. | | 4.5.1 Drug-Eluting Stents
    21. | | 4.5.2 Bare-Metal Stents
    22. | | 4.5.3 Bioabsorbable Stents
    23. | 4.6 Healthcare, BY Region (USD Billion)
    24. | | 4.6.1 North America
    25. | | | 4.6.1.1 US
    26. | | | 4.6.1.2 Canada
    27. | | 4.6.2 Europe
    28. | | | 4.6.2.1 Germany
    29. | | | 4.6.2.2 UK
    30. | | | 4.6.2.3 France
    31. | | | 4.6.2.4 Russia
    32. | | | 4.6.2.5 Italy
    33. | | | 4.6.2.6 Spain
    34. | | | 4.6.2.7 Rest of Europe
    35. | | 4.6.3 APAC
    36. | | | 4.6.3.1 China
    37. | | | 4.6.3.2 India
    38. | | | 4.6.3.3 Japan
    39. | | | 4.6.3.4 South Korea
    40. | | | 4.6.3.5 Malaysia
    41. | | | 4.6.3.6 Thailand
    42. | | | 4.6.3.7 Indonesia
    43. | | | 4.6.3.8 Rest of APAC
    44. | | 4.6.4 South America
    45. | | | 4.6.4.1 Brazil
    46. | | | 4.6.4.2 Mexico
    47. | | | 4.6.4.3 Argentina
    48. | | | 4.6.4.4 Rest of South America
    49. | | 4.6.5 MEA
    50. | | | 4.6.5.1 GCC Countries
    51. | | | 4.6.5.2 South Africa
    52. | | | 4.6.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Abbott (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Boston Scientific (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Medtronic (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Johnson & Johnson (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 B. Braun (DE)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Terumo (JP)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Cardinal Health (US)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Siemens Healthineers (DE)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Philips (NL)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY APPLICATION
    4. | 6.4 US MARKET ANALYSIS BY DEVICE TYPE
    5. | 6.5 US MARKET ANALYSIS BY END USER
    6. | 6.6 US MARKET ANALYSIS BY PROCEDURE TYPE
    7. | 6.7 US MARKET ANALYSIS BY TECHNOLOGY
    8. | 6.8 CANADA MARKET ANALYSIS BY APPLICATION
    9. | 6.9 CANADA MARKET ANALYSIS BY DEVICE TYPE
    10. | 6.10 CANADA MARKET ANALYSIS BY END USER
    11. | 6.11 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
    12. | 6.12 CANADA MARKET ANALYSIS BY TECHNOLOGY
    13. | 6.13 EUROPE MARKET ANALYSIS
    14. | 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
    15. | 6.15 GERMANY MARKET ANALYSIS BY DEVICE TYPE
    16. | 6.16 GERMANY MARKET ANALYSIS BY END USER
    17. | 6.17 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
    18. | 6.18 GERMANY MARKET ANALYSIS BY TECHNOLOGY
    19. | 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. | 6.20 UK MARKET ANALYSIS BY DEVICE TYPE
    21. | 6.21 UK MARKET ANALYSIS BY END USER
    22. | 6.22 UK MARKET ANALYSIS BY PROCEDURE TYPE
    23. | 6.23 UK MARKET ANALYSIS BY TECHNOLOGY
    24. | 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
    25. | 6.25 FRANCE MARKET ANALYSIS BY DEVICE TYPE
    26. | 6.26 FRANCE MARKET ANALYSIS BY END USER
    27. | 6.27 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
    28. | 6.28 FRANCE MARKET ANALYSIS BY TECHNOLOGY
    29. | 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
    30. | 6.30 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
    31. | 6.31 RUSSIA MARKET ANALYSIS BY END USER
    32. | 6.32 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
    33. | 6.33 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
    34. | 6.34 ITALY MARKET ANALYSIS BY APPLICATION
    35. | 6.35 ITALY MARKET ANALYSIS BY DEVICE TYPE
    36. | 6.36 ITALY MARKET ANALYSIS BY END USER
    37. | 6.37 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
    38. | 6.38 ITALY MARKET ANALYSIS BY TECHNOLOGY
    39. | 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
    40. | 6.40 SPAIN MARKET ANALYSIS BY DEVICE TYPE
    41. | 6.41 SPAIN MARKET ANALYSIS BY END USER
    42. | 6.42 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
    43. | 6.43 SPAIN MARKET ANALYSIS BY TECHNOLOGY
    44. | 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    45. | 6.45 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
    46. | 6.46 REST OF EUROPE MARKET ANALYSIS BY END USER
    47. | 6.47 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
    48. | 6.48 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
    49. | 6.49 APAC MARKET ANALYSIS
    50. | 6.50 CHINA MARKET ANALYSIS BY APPLICATION
    51. | 6.51 CHINA MARKET ANALYSIS BY DEVICE TYPE
    52. | 6.52 CHINA MARKET ANALYSIS BY END USER
    53. | 6.53 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
    54. | 6.54 CHINA MARKET ANALYSIS BY TECHNOLOGY
    55. | 6.55 INDIA MARKET ANALYSIS BY APPLICATION
    56. | 6.56 INDIA MARKET ANALYSIS BY DEVICE TYPE
    57. | 6.57 INDIA MARKET ANALYSIS BY END USER
    58. | 6.58 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
    59. | 6.59 INDIA MARKET ANALYSIS BY TECHNOLOGY
    60. | 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
    61. | 6.61 JAPAN MARKET ANALYSIS BY DEVICE TYPE
    62. | 6.62 JAPAN MARKET ANALYSIS BY END USER
    63. | 6.63 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
    64. | 6.64 JAPAN MARKET ANALYSIS BY TECHNOLOGY
    65. | 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    66. | 6.66 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
    67. | 6.67 SOUTH KOREA MARKET ANALYSIS BY END USER
    68. | 6.68 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
    69. | 6.69 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
    70. | 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
    71. | 6.71 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
    72. | 6.72 MALAYSIA MARKET ANALYSIS BY END USER
    73. | 6.73 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
    74. | 6.74 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
    75. | 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
    76. | 6.76 THAILAND MARKET ANALYSIS BY DEVICE TYPE
    77. | 6.77 THAILAND MARKET ANALYSIS BY END USER
    78. | 6.78 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
    79. | 6.79 THAILAND MARKET ANALYSIS BY TECHNOLOGY
    80. | 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
    81. | 6.81 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
    82. | 6.82 INDONESIA MARKET ANALYSIS BY END USER
    83. | 6.83 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
    84. | 6.84 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
    85. | 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
    86. | 6.86 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
    87. | 6.87 REST OF APAC MARKET ANALYSIS BY END USER
    88. | 6.88 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
    89. | 6.89 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
    90. | 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. | 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
    92. | 6.92 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
    93. | 6.93 BRAZIL MARKET ANALYSIS BY END USER
    94. | 6.94 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
    95. | 6.95 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
    96. | 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
    97. | 6.97 MEXICO MARKET ANALYSIS BY DEVICE TYPE
    98. | 6.98 MEXICO MARKET ANALYSIS BY END USER
    99. | 6.99 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
    100. | 6.100 MEXICO MARKET ANALYSIS BY TECHNOLOGY
    101. | 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
    102. | 6.102 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
    103. | 6.103 ARGENTINA MARKET ANALYSIS BY END USER
    104. | 6.104 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
    105. | 6.105 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
    106. | 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    107. | 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
    108. | 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    109. | 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
    110. | 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
    111. | 6.111 MEA MARKET ANALYSIS
    112. | 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    113. | 6.113 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
    114. | 6.114 GCC COUNTRIES MARKET ANALYSIS BY END USER
    115. | 6.115 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
    116. | 6.116 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
    117. | 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    118. | 6.118 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
    119. | 6.119 SOUTH AFRICA MARKET ANALYSIS BY END USER
    120. | 6.120 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
    121. | 6.121 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
    122. | 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
    123. | 6.123 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
    124. | 6.124 REST OF MEA MARKET ANALYSIS BY END USER
    125. | 6.125 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
    126. | 6.126 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
    127. | 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. | 6.128 RESEARCH PROCESS OF MRFR
    129. | 6.129 DRO ANALYSIS OF HEALTHCARE
    130. | 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. | 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. | 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. | 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    134. | 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    135. | 6.135 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
    136. | 6.136 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    137. | 6.137 HEALTHCARE, BY END USER, 2024 (% SHARE)
    138. | 6.138 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    139. | 6.139 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
    140. | 6.140 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
    141. | 6.141 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    142. | 6.142 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    143. | 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY END USER, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    8. | | 7.2.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    9. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    10. | | 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
    11. | | 7.3.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    12. | | 7.3.3 BY END USER, 2025-2035 (USD Billion)
    13. | | 7.3.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    14. | | 7.3.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    15. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
    17. | | 7.4.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    18. | | 7.4.3 BY END USER, 2025-2035 (USD Billion)
    19. | | 7.4.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    20. | | 7.4.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    21. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    22. | | 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
    23. | | 7.5.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    24. | | 7.5.3 BY END USER, 2025-2035 (USD Billion)
    25. | | 7.5.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    26. | | 7.5.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    27. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
    29. | | 7.6.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    30. | | 7.6.3 BY END USER, 2025-2035 (USD Billion)
    31. | | 7.6.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    32. | | 7.6.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    33. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
    35. | | 7.7.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    36. | | 7.7.3 BY END USER, 2025-2035 (USD Billion)
    37. | | 7.7.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    38. | | 7.7.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    39. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
    41. | | 7.8.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    42. | | 7.8.3 BY END USER, 2025-2035 (USD Billion)
    43. | | 7.8.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    44. | | 7.8.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    45. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    46. | | 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
    47. | | 7.9.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    48. | | 7.9.3 BY END USER, 2025-2035 (USD Billion)
    49. | | 7.9.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    50. | | 7.9.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    51. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
    53. | | 7.10.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    54. | | 7.10.3 BY END USER, 2025-2035 (USD Billion)
    55. | | 7.10.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    56. | | 7.10.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    57. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    58. | | 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
    59. | | 7.11.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    60. | | 7.11.3 BY END USER, 2025-2035 (USD Billion)
    61. | | 7.11.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    62. | | 7.11.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    63. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
    65. | | 7.12.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    66. | | 7.12.3 BY END USER, 2025-2035 (USD Billion)
    67. | | 7.12.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    68. | | 7.12.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    69. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    70. | | 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
    71. | | 7.13.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    72. | | 7.13.3 BY END USER, 2025-2035 (USD Billion)
    73. | | 7.13.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    74. | | 7.13.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    75. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
    77. | | 7.14.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    78. | | 7.14.3 BY END USER, 2025-2035 (USD Billion)
    79. | | 7.14.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    80. | | 7.14.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    81. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    82. | | 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
    83. | | 7.15.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    84. | | 7.15.3 BY END USER, 2025-2035 (USD Billion)
    85. | | 7.15.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    86. | | 7.15.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    87. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
    89. | | 7.16.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    90. | | 7.16.3 BY END USER, 2025-2035 (USD Billion)
    91. | | 7.16.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    92. | | 7.16.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    93. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
    95. | | 7.17.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    96. | | 7.17.3 BY END USER, 2025-2035 (USD Billion)
    97. | | 7.17.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    98. | | 7.17.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    99. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    100. | | 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
    101. | | 7.18.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    102. | | 7.18.3 BY END USER, 2025-2035 (USD Billion)
    103. | | 7.18.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    104. | | 7.18.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    105. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    106. | | 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
    107. | | 7.19.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    108. | | 7.19.3 BY END USER, 2025-2035 (USD Billion)
    109. | | 7.19.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    110. | | 7.19.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    111. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    112. | | 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
    113. | | 7.20.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    114. | | 7.20.3 BY END USER, 2025-2035 (USD Billion)
    115. | | 7.20.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    116. | | 7.20.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    117. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    118. | | 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
    119. | | 7.21.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    120. | | 7.21.3 BY END USER, 2025-2035 (USD Billion)
    121. | | 7.21.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    122. | | 7.21.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    123. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
    125. | | 7.22.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    126. | | 7.22.3 BY END USER, 2025-2035 (USD Billion)
    127. | | 7.22.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    128. | | 7.22.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    129. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    130. | | 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
    131. | | 7.23.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    132. | | 7.23.3 BY END USER, 2025-2035 (USD Billion)
    133. | | 7.23.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    134. | | 7.23.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    135. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    136. | | 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
    137. | | 7.24.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    138. | | 7.24.3 BY END USER, 2025-2035 (USD Billion)
    139. | | 7.24.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    140. | | 7.24.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    141. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    142. | | 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
    143. | | 7.25.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    144. | | 7.25.3 BY END USER, 2025-2035 (USD Billion)
    145. | | 7.25.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    146. | | 7.25.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    147. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    148. | | 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
    149. | | 7.26.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    150. | | 7.26.3 BY END USER, 2025-2035 (USD Billion)
    151. | | 7.26.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    152. | | 7.26.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    153. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    154. | | 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
    155. | | 7.27.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    156. | | 7.27.3 BY END USER, 2025-2035 (USD Billion)
    157. | | 7.27.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    158. | | 7.27.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    159. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    160. | | 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
    161. | | 7.28.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    162. | | 7.28.3 BY END USER, 2025-2035 (USD Billion)
    163. | | 7.28.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    164. | | 7.28.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    165. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    166. | | 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
    167. | | 7.29.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    168. | | 7.29.3 BY END USER, 2025-2035 (USD Billion)
    169. | | 7.29.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    170. | | 7.29.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    171. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    172. | | 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
    173. | | 7.30.2 BY DEVICE TYPE, 2025-2035 (USD Billion)
    174. | | 7.30.3 BY END USER, 2025-2035 (USD Billion)
    175. | | 7.30.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    176. | | 7.30.5 BY TECHNOLOGY, 2025-2035 (USD Billion)
    177. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    178. | | 7.31.1
    179. | 7.32 ACQUISITION/PARTNERSHIP
    180. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

  • Coronary Artery Disease
  • Acute Coronary Syndrome
  • Stable Angina
  • Unstable Angina

Healthcare By Device Type (USD Billion, 2025-2035)

  • Balloon Catheters
  • Stents
  • Guidewires
  • Sheaths

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Cardiac Catheterization Labs
  • Ambulatory Surgical Centers

Healthcare By Procedure Type (USD Billion, 2025-2035)

  • Elective Procedures
  • Emergency Procedures
  • Diagnostic Procedures

Healthcare By Technology (USD Billion, 2025-2035)

  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bioabsorbable Stents
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓